Cost-effectiveness as an outcome in randomized clinical trials
- 1 December 2006
- journal article
- review article
- Published by SAGE Publications in Clinical Trials
- Vol. 3 (6), 543-551
- https://doi.org/10.1177/1740774506073105
Abstract
Background Economic outcomes are now included in many contemporary randomized trials and provide an additional dimension to the assessment of interventions. Economic data collection and analysis pose several methodologic challenges, however.Keywords
This publication has 20 references indexed in Scilit:
- Conducting economic evaluations alongside multinational clinical trials: Toward a research consensusAmerican Heart Journal, 2005
- Medical economics and the assessment of value in cardiovascular medicine: Part II.Circulation, 2002
- Medical economics and the assessment of value in cardiovascular medicine: Part I.Circulation, 2002
- Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular TachyarrhythmiasCirculation, 2002
- Cost-Effectiveness of the Implantable Cardioverter-DefibrillatorCirculation, 2001
- Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac ArrestCirculation, 2000
- Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)The Lancet, 1998
- The Cost-effectiveness of Automatic Implantable Cardiac Defibrillators:Circulation, 1998
- Methods for Comparison of Cost DataAnnals of Internal Medicine, 1997
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994